Evogene (EVGN) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Lake Street | Maintained | Buy | $3.50 from $5.00 | May 22, 2025 |
| Alliance Global Partners | Initiated Coverage | Buy | $1.85 | Oct 2, 2023 |
| Lake Street | Maintained | Buy | $3.00 from $2.00 | Aug 18, 2023 |
| Roth MKM | Maintained | Buy | $6.00 from $1.00 | Jul 21, 2023 |
Frequently asked questions
Is EVGN a buy, sell, or hold?
Analysts covering Evogene currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on EVGN?
On May 22, 2025, Lake Street maintained Evogene at Buy with a price target of $3.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.